Dilaudid and Nail infection - a phase IV clinical study of FDA data

Summary:

Nail infection is reported as a side effect among people who take Dilaudid (hydromorphone hydrochloride), especially for people who are female, 40-49 old, also take Actemra, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Nail infection when taking Dilaudid. It is created by eHealthMe based on reports of 95,518 people who have side effects when taking Dilaudid from the FDA, and is updated regularly.

What is Dilaudid?

Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 96,466 Dilaudid users. Check the latest studies of Dilaudid.

What is Nail infection?

Nail infection is found to be associated with 299 drugs and 508 conditions by eHealthMe. Check the latest studies of Nail infection.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

95,518 people reported to have side effects when taking Dilaudid.
Among them, 33 people (0.03%) have Nail infection.

Among these 33 people:

What is the gender of people who have Nail infection when taking Dilaudid? *

female: 96.88 %
male: 3.12 %

What is the age of people who have Nail infection when taking Dilaudid? *

What are other drugs people take besides Dilaudid? *

What are other side effects people have besides Nail infection? *

Weight Increased: 29 people, 87.88%
Infusion Related Reaction: 29 people, 87.88%
Blood Pressure Systolic Increased: 29 people, 87.88%
Oropharyngeal Pain: 29 people, 87.88%
Diarrhea: 29 people, 87.88%
Rashes (redness): 29 people, 87.88%
Urinary Tract Infection: 29 people, 87.88%
Weight Decreased: 29 people, 87.88%
Cough: 25 people, 75.76%
Fever: 24 people, 72.73%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 29 people, 87.88%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 6.06%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 3.03%
Neck Pain: 1 person, 3.03%
Lipidosis (disorder of lipid metabolism involving abnormal accumulation of lipids in the reticuloendothelial cells): 1 person, 3.03%
Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 1 person, 3.03%
Diabetes: 1 person, 3.03%
Carpal Tunnel Syndrome (nerve compression at wrist results numbness weakness, pain , swelling): 1 person, 3.03%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Dilaudid and have Nail infection?

- Check whether Nail infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dilaudid:

Dilaudid (96,466 reports)

Nail infection treatments and more:

Nail infection (2,344 reports)

Browse all side effects of Dilaudid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nail infection:

Nail infection (299 drugs)

Browse all the conditions that are associated with Nail infection:

Nail infection (508 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydromorphone hydrochloride (the active ingredients of Dilaudid) and Dilaudid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.